Posted by Michael Wonder on 22 Oct 2020
Oxford developed COVID-19 vaccine, then scholars clashed over money
21 October 2020 - Early deal with Merck was scotched for fear poor countries would be left out; now university could make over $100 million with AstraZeneca if technology succeeds.
Just weeks before the University of Oxford announced a mega-deal aimed at rolling out a COVID-19 vaccine world-wide, university leaders had a revolt on their hands.
Publicly, Oxford scientists were touting progress in the laboratory. But behind the scenes, two renowned vaccinologists leading the effort were fighting a proposed deal with U.S. pharmaceutical giant Merck & Co.
